Siemens Healthineers has launched an app designed for Apple Vision Pro that enables users such as surgeons, medical students, or patients to view immersive, interactive holograms of the human body captured through medical scans in their real-world environment. Visualizing the renderings through the app could assist in surgical planning and medical education, or help patients […]
A systemic cause of patient harm could be better avoided with the help of technology, following the launch of Miya Results Tracking by health tech company Alcidion.
German company FUSE-AI, a developer of artificial intelligence for radiology, has received EU Medical Device Regulation (MDR) 2017/745 IIa certification for its AI software “Prostate.Carcinoma.ai”.
At this year’s ECR in Vienna, FUJIFILM Healthcare Europe launched the ECHELON Synergy – a revolutionary MRI scanner for efficient, high performance imaging with a focus on patient comfort. The 1.5 Tesla superconductive system employs AI-powered Synergy deep learning reconstruction to enhance the sharpness of images and the speed of scanning for maximum efficiency.
Varian, a Siemens Healthineers company, has received 510(k) clearance from the U.S. FDA for the TrueBeam and Edge radiotherapy systems featuring the HyperSight imaging solution.
At this year’s ECR in Vienna, Philips introduced the Philips CT 5300 system equipped with advanced AI capabilities designed to be used for diagnosis, interventional procedures and screening. This flexible CT system in reases diagnostic confidence, streamlines workflow efficiency, and maximizes system up-time, helping to improve patient outcomes and department productivity.
Following the recent CE approval of the Solia S lead (1) for Left Bundle Branch Area Pacing (LBBAP), BIOTRONIK now provides the world’s first and only complete CSP system, fully CE-approved for LBBAP. (2)
Aston University has hosted an event to celebrate the launch of SPARK The Midlands www.sparkthemidlands.co.uk, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagnostics, and real-world clinical use.
An initiative with the aim of building stronger relationships between the NHS and industry was recently hosted and organised by the Imperial College Healthcare NHS Trust, in partnership with the Shelford Group and the Association of British HealthTech Industries (ABHI).
Affluent Medical, a French clinical-phase MedTech company specializing in the international development and industrialization of innovative medical prostheses, has carried out a successful first-in-human implantation of the minimally invasive medical device Artus for the treatment of urinary incontinence as part of the European pilot study ‘Dry’.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
